Literature DB >> 8194559

Intelligence in mild atypical phenylketonuria.

P M Costello1, M G Beasley, S L Tillotson, I Smith.   

Abstract

In 82 children with mild phenylketonuria (PKU) (blood phenylalanine (Phe) concentrations consistently below 900 mumol/l throughout follow up) the relationship between intelligence at age 4 (IQ by Stanford-Binet) and average blood Phe concentrations from birth to 4 years was examined. Of the 82 children 24 had received no treatment. In the group as a whole, and in the 24 untreated subjects alone, mean IQs were significantly below population norms, with deficits of approximately 4.5 points and 9 points respectively. After allowing for social class IQ fell progressively by approximately 6 points for each 100 mumol/l rise in mean Phe concentrations in both the treated and untreated subjects. This relationship resembled that previously reported in early treated children with more severe forms of PKU, except that the scale of the relationship was even greater. We conclude that all children whose blood Phe concentrations reach 400 mumol/l or above should receive a low Phe diet, at least during the preschool years, and that the aim should be to control blood Phe levels below 400 mumol/l throughout early childhood in all forms of PKU.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194559     DOI: 10.1007/bf01954515

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

2.  Unrecognized adult phenylketonuria. Implications for obstetrics and psychiatry.

Authors:  T L Perry; S Hansen; B Tischler; F M Richards; M Sokol
Journal:  N Engl J Med       Date:  1973-08-23       Impact factor: 91.245

3.  Atypical phenylketonuria. An approach to diagnosis and management.

Authors:  J S Yu; S J Stuckey; M T O'Halloran
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

4.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

5.  Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

6.  Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemia.

Authors:  S E Waisbren; R Schnell; H L Levy
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

Review 7.  Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood.

Authors:  F Güttler
Journal:  Acta Paediatr Scand Suppl       Date:  1980

8.  Review of neonatal screening programme for phenylketonuria.

Authors:  I Smith; B Cook; M Beasley
Journal:  BMJ       Date:  1991-08-10

9.  Routine neonatal screening for phenylketonuria in the United Kingdom 1964-78. Medical Research Council Steering Committee for the MRC/DHSS Phenylketonuria Register.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-23

10.  Intellectual development and academic achievement of children treated early for phenylketonuria.

Authors:  H K Berry; D J O'Grady; L J Perlmutter; M K Bofinger
Journal:  Dev Med Child Neurol       Date:  1979-06       Impact factor: 5.449

  10 in total
  5 in total

1.  Commentary: What degree of hyperphenylalaninaemia requires treatment?

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2012-06-21       Impact factor: 4.982

2.  Untreated non-phenylketonuric-hyperphenylalaninaemia: intellectual and neurological outcome.

Authors:  J Weglage; K Ullrich; M Pietsch; B Fünders; R Zass; H G Koch
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 4.  Mild hyperphenylalaninemia: to treat or not to treat.

Authors:  Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

5.  Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency.

Authors:  Amelie S Lotz-Havla; Katharina Weiß; Katharina Schiergens; Stephanie Regenauer-Vandewiele; Klaus G Parhofer; Tara Christmann; Luise Böhm; Joachim Havla; Esther M Maier
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.